Earli, Inc.

01/08/2026

Earli, Inc. is on NPR Biotech Nation across all U.S. NPR radio stations this week, in the runup to the global J.P. Morgan Health Conference in San Francisco. Earli is running (not marching) towards a cancer therapeutics trial in humans in the next 18 months. How does it work? Earli has developed “genetic switches” that only turn on in cancer cells and reprogram them so they have to make therapies against themselves. These therapies activate the immune system to attack and kill the cancer.

Spotify podcast link below.


https://open.spotify.com/episode/2pCWyALvemxy9QyhEXT8Mk?si=TbNPpiOVTX-XxZQff_P3Tw

Jorge Conde Vinod Khosla Marc Andreessen
David Suhy Badriprasad Ananthanarayanan

BioTech Nation ... with Dr. Moira Gunn · Episode

01/08/2026

Earli, Inc. is on NPR Biotech Nation across all U.S. NPR radio stations this week, in the runup to the global J.P. Morgan Health Conference in San Francisco. Earli is running (not marching) towards a cancer therapeutics trial in humans in the next 18 months. How does it work? Earli has developed “genetic switches” that only turn on in cancer cells and reprogram them so they have to make therapies against themselves. These therapies activate the immune system to attack and kill the cancer.

Spotify podcast link below.


https://open.spotify.com/episode/2pCWyALvemxy9QyhEXT8Mk?si=TbNPpiOVTX-XxZQff_P3Tw

Jorge Conde Vinod Khosla Marc Andreessen
David Suhy Badriprasad Ananthanarayanan

BioTech Nation ... with Dr. Moira Gunn · Episode

12/06/2024

‘Tis the season at Earli. Leading-edge Bio lab meets tradition.
Happy Holiday season to all of you!

11/26/2024

On the intersection where biology meets software and engineering, we will see of the biggest impacts on humanity by AI. As an example, Earli’s early cancer detection and treatment technology wouldn’t exist without AI and machine learning. 20,000 fully DNA-sequenced cancer samples and thousands of images have been running through an AI pipeline we built in the last years. Next, we are building an *AI Flywheel* that is designed to make it ever more accurate to determine what is cancer and what is not. After all, you can only “kill the bad cells and not the good cells” if you know which is which. It’s the Holy Grail in cancer.

Henry Lee, a senior biotechnician, has seen how AI powers Earli’s mission—automating cancer imaging, designing proteins, and driving breakthroughs to transform early cancer detection and treatment.

07/19/2024

Earli, Inc.’s early cancer detection and treatment technology featured by Germany’s largest consumer news outlet, BILD: https://www.bild.de/leben-wissen/krebs-neue-technologie-zwingt-krebszellen-sich-selbst-zu-enttarnen-668e8f60a76a581c61f687fc

Bild

US-Forscher arbeiten an einer Technologie, die Krebszellen dazu zwingt, sich selbst zu enttarnen. Wie das die Krebsfrüherkennung revolutionieren könnte.

05/10/2023

Imagine a doctor tells you “We have found something in your body that might be cancer. But we don’t know, for sure, so we will just watch it. Come back in twelve months, and we will check if it has grown by then.” You go home that day and then worry for a year whether you have cancer. If you do, you will have lost a precious year of treatment that might have prevented metastases. Sounds crazy? Happens millions of times a year. We don’t just need more early detection - we need more Early Intervention to save thousands of lives every year. Today we published this opinion piece in Newsweek.

Marc Andreessen Reid Garrett Hoffman Jorge Conde Khosla Ventures Vinod Khosla

We need early cancer detection that leads to early intervention.

01/05/2023

How best to describe the spirit at Earli? Well, perhaps Halloween is a good example. Things can get rather interesting at Earli. :)
https://www.earli.com/post/an-earli-halloween

12/08/2022

As a Holiday gift, Earli's story and technology is featured in WIRED magazine. 🙂
How would a world look like where we could find AND treat cancer at the earliest stages? It may be hard to believe, but it's true: Early detection is the *single biggest* lever to increase survival rates of cancer - more than any medicine or treatment. For lung cancer, the difference between a Stage 1 detection and Stage 4 detection is a 10x (!) higher 5-year survival rate. Liver cancer - 12x. Pancreatic cancer - 14x.
Were going for a moonshot at Earli. Wish us luck. We are getting closer and closer.
https://www.wired.com/story/making-cancer-reveal-itself/
WIRED Khosla Ventures Perceptive Advisors World Economic Forum

Medtech firm Earli is working on a way to make tumors announce themselves as they appear—and even provide directions to where they are in the body.

06/29/2022

This is Earli, Inc.'s co-founder and CEO Cyriac Roeding's recent interview with the City of Sydney's entrepreneurship program and Sallyann Williams, the CEO of Cicada Innovations, a thriving Australian co-working space. The Australian entrepreneurship community is alive, and Australia is the place to go for clinical trials done faster and yet at top notch quality.

Forty percent of us will develop cancer in our lifetime. What if we found and treated cancer early? How many lives could it save? How much burden would it ta...

01/18/2022

Leading-edge science is at the core of Earli. Here is the interview with the person who is responsible at Earli for turning ideas into bonfires of action. Co-founder and chief scientific officer David Suhy.

An interview with David Suhy, the Chief Science Officer and cofounder of Earli, on synthetic biopsy, the benefits of working on medical tech in a commercial context, and more.